EKNL Stock Overview

Through its joint venture interest in NeuroVasc Clinical Inc., promotes and distributes frequency rhythmic electrical modulation system equipment used in the treatment of peripheral neuropathy in Canada. More details

EKNL fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Latest financial reports are more than a year old

Shares are highly illiquid

Does not have a meaningful market cap ($316)

My Notes

Capture your thoughts, links and company narrative

EKO International Corp. Competitors

E Automotive

OTCPK:EICC.F

US$6.0k

NAPC Defense

OTCPK:BLIS

US$3.8m

Sentage Holdings

NasdaqCM:SNTG

US$5.3m

ADM Endeavors

OTCPK:ADMQ

US$6.3m

Price History & Performance

Summary of share price highs, lows and changes for EKO International
Historical stock prices
Current Share Price	US$0.00001
52 Week High	US$0.0002
52 Week Low	US$0.00001
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	-99.91%
5 Year Change	-99.50%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	EKNL	US Commercial Services	US Market
7D	0%	2.1%	0.6%
1Y	n/a	24.0%	24.5%

Return vs Industry: Insufficient data to determine how EKNL performed against the US Commercial Services industry.

Return vs Market: Insufficient data to determine how EKNL performed against the US Market.

Price Volatility

Is EKNL's price volatile compared to industry and market?
EKNL volatility
EKNL Average Weekly Movement	n/a
Commercial Services Industry Average Movement	8.5%
Market Average Movement	6.5%
10% most volatile stocks in US Market	18.8%
10% least volatile stocks in US Market	3.2%

Stable Share Price: EKNL has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine EKNL's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	n/a	n/a

EKO International Corp., through its joint venture interest in NeuroVasc Clinical Inc., promotes and distributes frequency rhythmic electrical modulation system equipment used in the treatment of peripheral neuropathy in Canada. The company, through its joint venture interest in NeuroVasc Clinical Inc., also sets up and/or manage clinics to treat patients using FREMSTM equipment. EKO International Corp. is based in Burlington, Canada.

EKO International Corp. Fundamentals Summary

How do EKO International's earnings and revenue compare to its market cap?
EKNL fundamental statistics
Market cap	US$316.00
Earnings (TTM)	US$30.88k
Revenue (TTM)	n/a

0.0x

P/E Ratio

0.0x

P/S Ratio

Is EKNL overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EKNL income statement (TTM)
Revenue	-US$970.19k
Cost of Revenue	-US$431.59k
Gross Profit	-US$538.60k
Other Expenses	-US$569.48k
Earnings	US$30.88k

Last Reported Earnings

Mar 31, 2011

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did EKNL perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/05/20 19:51
End of Day Share Price	2024/02/21 00:00
Earnings	2011/03/31
Annual Earnings	2010/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

EKO International Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution